IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1794 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (911 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed3099    
    Printed62    
    Emailed0    
    PDF Downloaded117    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2015  |  Volume : 81  |  Issue : 4  |  Page : 400-402

Primary localized cutaneous nodular amyloidosis with bullous lesions


1 Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 Zhongshan Hospital, Wuhan, China

Date of Web Publication3-Jul-2015

Correspondence Address:
Prof. Changzheng Huang
Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.157459

Rights and Permissions



How to cite this article:
Sanusi T, Li Y, Qian Y, Huang C. Primary localized cutaneous nodular amyloidosis with bullous lesions. Indian J Dermatol Venereol Leprol 2015;81:400-2

How to cite this URL:
Sanusi T, Li Y, Qian Y, Huang C. Primary localized cutaneous nodular amyloidosis with bullous lesions. Indian J Dermatol Venereol Leprol [serial online] 2015 [cited 2019 Dec 15];81:400-2. Available from: http://www.ijdvl.com/text.asp?2015/81/4/400/157459


Sir,

A 43-year-old Chinese female presented with a 3-year history of mildly pruritic bullous skin eruptions on the upper and right lower back. Examination showed flaccid and yellowish-brown bullae surrounded by erythematous plaques on the upper back and hypopigmentation in the center and clear bullae over the right lower back. The bullae were 6 × 3.5 cm in diameter on the upper back and 1 × 1 cm in diameter on the right lower back [Figure 1]. Mucous membranes and tongue were normal. Systemic examination revealed no abnormality.
Figure 1: (a) Bullous skin eruptions on the upper and right lower back, (b) Large bullae on the upper trunk, flaccid, and yellowish-brown color surrounded by erythematous plaque, (c) Small clear bullae on the right of the lower back


Click here to view


Complete blood count, renal function, liver function and urinalysis were normal. Antinuclear antibody (ANA), extractable nuclear antigen (ENA) screen, qualitative urine porphyrin, serum protein electrophoresis and urine for Bence Jones protein were normal or negative. Roentgenogram and electrocardiogram were normal.

A skin biopsy from the edge of a bulla on the upper back showed subepidermal clefts and mass-like pink colored amorphous deposits in the papillary and reticular dermis which were positive when stained by crystal violet. Congo red staining was also positive and revealed apple-green birefringence with polarized light. There were a few plasma cells around the blood vessels [Figure 2]. Immunohistochemistry studies showed strong positivity for λ light chain and a comparatively lesser intensity for κ light chain [Figure 3]. Based on the clinical findings and histologic characteristics of the skin lesions, diagnosis of a primary localized cutaneous nodular amyloidosis (PLCNA) with bullous appearance was made. The lesions were removed by surgical excision.
Figure 2: (a and b) Subepidermal clefts and mass-like pink colored amorphous materials deposition in the papillary and reticular dermis (H and E, ×20, ×40), (c) Plasma cells infiltration around the blood vessels (H and E, ×200)


Click here to view
Figure 3: (a) Subepidermal cleft and amyloid deposition in the entire dermis was positive with violet staining (×100) and (b) Congo red staining (×40), also positive for apple-green birefringence with polarized light (not shown). (c) Immunohistochemistry staining showed strong positivity for λ light chain (×200) and (d) less intensity for κ light chain (×200)


Click here to view


Primary localized cutaneous nodular amyloidosis is a rare variant of cutaneous amyloidosis. Approximately 100 cases of nodular cutaneous amyloidosis have been reported in the medical literature. [1] Cutaneous nodular amyloidosis is composed of light-chain immunoglobulins (AL amyloid) derived from a monoclonal expansion of plasma cells. The amyloid infiltrates the entire dermis from the papillary dermis to the subcutis. The amyloid deposits may also be seen in the vessels and nerve sheath. The condition commonly occurs on the legs, feet, trunk, face and genitalia. It presents typically with single or multiple waxy yellow-red nodules. [2] However, the lesions may be indistinguishable from cutaneous lesions of primary systemic amyloidosis. Immunohistochemical analysis of the dermal deposits of amyloid has revealed that the light chains may be λ or κ, or that both may be present. [3]

Bullous lesions of cutaneous amyloidosis are commonly associated with systemic amyloidosis with multiorgan involvement, including primary systemic amyloidosis and myeloma-associated amyloidosis. However, several patients of localized bullous cutaneous amyloidosis without systemic involvement have been described. [4] The bullae can be either intradermal or subepidermal, often induced by trauma or friction which are described as tense painful blisters that are frequently hemorrhagic. [5]

The mechanism of blister formation in cases of cutaneous amyloidosis remains to be described. Ochiai et al.[4] suggested that the amyloid globules might be engulfed through the process of transepidermal elimination initiated by trauma or rubbing which are induced by persistent pruritus that acts as the local precipitating factor for blister formation.

The treatment of primary localized cutaneous nodular amyloidosis includes surgical excision, cryotherapy, electrodesiccation and curettage, intralesional steroid injection and treatment with the CO 2 laser, each with different results. Nevertheless, the lesions are difficult to treat and often recur after treatment. The progression of primary localized cutaneous nodular amyloidosis to systemic amyloidosis has been reported in some case series at the rate of 7-50%. [3] Electron microscopy has shown that the deposits of amyloid, either primary or secondary type, consist of accumulation of rigid non-branching fibrils which are responsible for the Congo Red birefringence seen on polarized light microscopy. [2],[5] Systemic evaluation and long-term follow-up is needed to monitor the progression to systemic amyloidosis. We were able to find only one previous report of this presentation. [6]

 
  References Top

1.
Santos-Juanes J, Galache C, Curto JR, Astudillo A, Sanchez del Rio J. Nodular primary cutaneous amyloidosis. J Eur Acad Dermatol Venereol 2004;18:224-6.  Back to cited text no. 1
    
2.
Fernandez-Flores A. Cutaneous amyloidosis: A concept review. Am J Dermatopathol 2012;34:1-14.  Back to cited text no. 2
    
3.
Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis: A long-term follow-up study. Br J Dermatol 2001;145:105-9.  Back to cited text no. 3
    
4.
Ochiai T, Morishima T, Hao T, Takayama A. Bullous amyloidosis: The mechanism of blister formation revealed by electron microscopy. J Cutan Pathol 2001;28:407-11.  Back to cited text no. 4
    
5.
Lachmann HJ, Hawkins PN. Amyloidosis of the Skin. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick′s dermatology in general medicine. 8 th ed. New York: McGraw-Hill; 2012. p. 1574-83.  Back to cited text no. 5
    
6.
LaChance A, Phelps A, Finch J, Lu J, Elaba Z, Rezuke W, et al. Nodular cutaneous amyloidosis: A bullous variant. Clin Exp Dermatol 2014;39:344-7.  Back to cited text no. 6
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow